Israeli Funds Raise Patient Payments

21 July 1996

The Israeli sick funds have increased patient copayments on prescriptions, in the majority of cases by 8.3%, which is the rise in the cost of living index since the last increase, in December 1995.

An average copayment is now a minimum of NIS6-NIS6.5 ($1.8-$2.0) for 10 tablets or an original pack (usually a month's treatment) or, in the case of the smaller funds, 10% of the retail price.

Furthermore, in the framework of the proposed Ministry of Health budget reductions, the Treasury has indicated that from next year, patients will have to pay NIS10 for a visit to a physician, NIS20 for a visit to an out-patient specialist, and NIS40 per day for hospitalization. There is also a proposal for a one-time 25% increase in the level of drug copayments.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight